Related Experiment Video
Updated: Jun 8, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
[Novel approaches for the prevention of influenza: the intradermal vaccination]
Paolo Durando1, Laura Sticchi, Marisa Alberti
1Dipartimento di Scienze della Salute, Università degli Studi di Genova, Ambulatorio Vaccinazioni e Sperimentazioni Cliniche, Genova.
Abstract:
Conventional non-adjuvanted influenza vaccines have shown suboptimal immunogenicity in subjects at high risk for complications, such as the elderly. Between the several strategies proposed to develop more immunogenic vaccines than the conventional ones, a promising option is represented by the administration of non-adjuvanted vaccine through the intradermal (ID) route. This paper summarizes and discusses the main results recently obtained in clinical trials investigating the safety, tolerability and immunogenicity of new ID influenza vaccines, containing standard or reduced antigen dosages, in different age-groups.
Related Concept Videos
Vaccinations
Vaccines
Influenza
Smallpox
Inhibitors Of Virion Release
